nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aiming for the cure in myeloma: Putting our best foot forward
|
Bar, Noffar |
|
|
62 |
C |
p. |
artikel |
2 |
Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data
|
Bosi, Alessandro |
|
|
62 |
C |
p. |
artikel |
3 |
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline
|
Di Minno, Giovanni |
|
|
62 |
C |
p. |
artikel |
4 |
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
|
Stahl, Maximilian |
|
|
62 |
C |
p. |
artikel |
5 |
Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies
|
Duléry, Rémy |
|
|
62 |
C |
p. |
artikel |
6 |
Combining PTCy and ATG for GvHD prophylaxis in non-malignant diseases
|
DeZern, Amy E. |
|
|
62 |
C |
p. |
artikel |
7 |
Current approach to Waldenström macroglobulinemia
|
Kapoor, Prashant |
|
|
62 |
C |
p. |
artikel |
8 |
Does PTCY increase the risk of infections?
|
Mikulska, Malgorzata |
|
|
62 |
C |
p. |
artikel |
9 |
Editorial Board
|
|
|
|
62 |
C |
p. |
artikel |
10 |
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond
|
Gooptu, Mahasweta |
|
|
62 |
C |
p. |
artikel |
11 |
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?
|
Santagata, D. |
|
|
62 |
C |
p. |
artikel |
12 |
Haploidentical bone marrow transplants with post transplant cyclophosphamide on day + 3 + 5: The Genova protocol
|
Raiola, Anna Maria |
|
|
62 |
C |
p. |
artikel |
13 |
Haploidentical transplants with a G-CSF/ATG-based protocol: Experience from China
|
Xu, Zheng-Li |
|
|
62 |
C |
p. |
artikel |
14 |
Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management
|
Panch, Sandhya R. |
|
|
62 |
C |
p. |
artikel |
15 |
Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification
|
Li, Yun |
|
|
62 |
C |
p. |
artikel |
16 |
Preservation of fertility in female patients with hematologic diseases
|
Antunes, Marika Bini |
|
|
62 |
C |
p. |
artikel |
17 |
Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review
|
Eising, H.P. |
|
|
62 |
C |
p. |
artikel |
18 |
PTCy: The “new” standard for GVHD prophylaxis
|
Bacigalupo, Andrea |
|
|
62 |
C |
p. |
artikel |
19 |
Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight
|
McCurdy, Shannon R. |
|
|
62 |
C |
p. |
artikel |
20 |
Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the diverse applications of machine learning
|
Elhadary, Mohamed |
|
|
62 |
C |
p. |
artikel |
21 |
Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
|
Santinelli, Enrico |
|
|
62 |
C |
p. |
artikel |
22 |
The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment
|
Darwish, Christina |
|
|
62 |
C |
p. |
artikel |
23 |
The development of post-transplant cyclophosphamide: Half a century of translational team science
|
O'Donnell, Paul V. |
|
|
62 |
C |
p. |
artikel |
24 |
The next horizon now that everyone has a donor: Precision allogeneic transplantation
|
Jones, Richard J. |
|
|
62 |
C |
p. |
artikel |
25 |
Using artificial intelligence to improve body iron quantification: A scoping review
|
Nashwan, Abdulqadir J. |
|
|
62 |
C |
p. |
artikel |